Ann Plast Reconstr Surg | Volume 7, Issue 2 | Research Article | Open Access

Outcomes of Mohs Micrographic Surgery for Periocular Squamous Cell Carcinoma

Hartley MJ*, Meredith PR and Oliphant T

Department of Ophthalmology, Royal Victoria Infirmary, Newcastle-Upon-Tyne, UK

*Correspondance to: Matthew J Hartley 

Fulltext PDF


Periocular cutaneous Squamous Cell Carcinoma (cSCC) accounts for 5% to 10% of all eyelid malignancies. Periocular cSCC carries a low mortality rate but can be destructive to local tissues, which can be devastating if neglected. Due to the unique function and anatomy of the eyelids, Mohs Micrographic Surgery (MMS) is gold standard for treating cSCC to preserve healthy tissue and reduce rates of local recurrence. In this study, we reviewed 34 patients who underwent MMS for periocular cSCC in the North of England after a minimum period of 24 months post-surgery to assess recurrence rate and therefore success of MMS. Two patients (5.9%) had local recurrence of periocular cSCC, which is comparable to the literature. Median time elapsed since MMS was 60 months. A variety of oculoplastic surgical techniques were utilized in the repair of the Mohs defect. One patient (2.9%) developed a significant post-operative complication following repair of their Mohs defect.




Hartley MJ, Meredith PR, Oliphant T. Outcomes of Mohs Micrographic Surgery for Periocular Squamous Cell Carcinoma. Ann Plast Reconstr Surg. 2023; 7(2): 1110..

Subscribe to Our Newsletter